Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

T2 Biosystems, Inc. (TTOO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

0.5100

+0.0842

(+19.77%)

At close: 04:00PM EST

0.5199

+0.01

(+1.94%)

After hours:

07:44PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	10.73M
Enterprise Value	27.59M
Trailing P/E	0.07
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.70
Price/Book (mrq)	N/A
Enterprise Value/Revenue	3.59
Enterprise Value/EBITDA	-0.85

Trading Information

Stock Price History

Beta (5Y Monthly)	0.38
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	8.3800
52 Week Low ³	0.4160
50-Day Moving Average ³	1.3506
200-Day Moving Average ³	3.5541

Share Statistics

Avg Vol (3 month) ³	516.57k
Avg Vol (10 day) ³	864.26k
Shares Outstanding ⁵	21.04M
Implied Shares Outstanding ⁶	N/A
Float ⁸	4.12M
% Held by Insiders ¹	10.17%
% Held by Institutions ¹	73.51%
Shares Short (Oct 31, 2024) ⁴	834.76k
Short Ratio (Oct 31, 2024) ⁴	1.26
Short % of Float (Oct 31, 2024) ⁴	5.01%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	4.78%
Shares Short (prior month Sep 30, 2024) ⁴	355.34k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-490.52%

Management Effectiveness

Return on Assets (ttm)	-90.46%
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	7.16M
Revenue Per Share (ttm)	1.00
Quarterly Revenue Growth (yoy)	-0.60%
Gross Profit (ttm)	N/A
EBITDA	-42.13M
Net Income Avi to Common (ttm)	-48.26M
Diluted EPS (ttm)	-0.0300
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	4.25M
Total Cash Per Share (mrq)	0.24
Total Debt (mrq)	19.22M
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.60
Book Value Per Share (mrq)	-6.91

Cash Flow Statement

Operating Cash Flow (ttm)	-43.73M
Levered Free Cash Flow (ttm)	-31.85M